Effects Other than Relaxation of Non-Depolarizing Muscle Relaxants

  • E. Sylvester Vizi


It is important that anesthesiologists be aware of the possible side effects of the muscle relaxants (MR) they use. Although several reviews have dealt with this subject (Paton, 1959; Foldes, 1960; Bowman, 1982; 1990; Hunter, 1987; Miller, 1992; Lien, 1994), they mainly summarized the unwanted effects of MRs from the clinical point of view and paid little attention to the mechanism of these actions, despite the fact that not infrequently the lack of such knowledge has led to improper selection of muscle relaxants (MR) and subsequently to operative and postoperative complications.


Nicotinic Receptor Myenteric Plexus Neuromuscular Blocking Drug nAChR Antagonist nAChR Agonist 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. ReferencesGoogle Scholar
  2. Alkonkon, M. and Albuquerque, E.X. (1993) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. J. Pharmacol. Exp. 265:1455–1473.Google Scholar
  3. Anand, R., Conroy, W.G., Schoepter, R., Whiting, P. and Lindstrom, I. (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocyles have a pentameric quaternary structure. J. Biol. Chem. 266:11192–11198.PubMedGoogle Scholar
  4. Beranek, R. and Vyskocil, F. (1967) The action of tubocurarine and atropine on normal and denervated rat diaphragm. J. Physiol. (Lond) 188:53–66.Google Scholar
  5. Bowman, W.C. (1980) Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth. and Analg. 59: 935–943.Google Scholar
  6. Bowman, W.C. (1990) Pharmacology of neuromuscular function. John Wright, Bristol.Google Scholar
  7. Bowman, W.C. (1982) Non-relaxant properties of neuromuscular blocking drugs. Br.J.Anaesth. 54:147–160.PubMedCrossRefGoogle Scholar
  8. Bowman, W.C. and Webb, S.N. (1972) Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat. J. Pharm. Pharmacol. 24:762–772.PubMedCrossRefGoogle Scholar
  9. Bowman, W.C. and Webb, S.N. (1976) Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat. Clin.Exp. Pharmacol. Physiol. 3:545–555.PubMedCrossRefGoogle Scholar
  10. Cardone, C., Szenohradszky, J., Yost, S. and Bickler, P.E. (1994) Activation of brain acetylcholine receptors by neuromuscular blocking drugs. Anesthesiology, 80:1155–1161.PubMedCrossRefGoogle Scholar
  11. Clarke, R.S.J, and Mirakhur, R.K. (1994) Adverse effect of muscle relaxants. Adverse Drug React. Toxicol. Rev. 13:23–41.PubMedGoogle Scholar
  12. Coleman, A.J., Downing, J.W., Leary, W.P., Moyes, D.G. and Styles, M. (1972) The immediate cardiovascular effects of pancuronium, alcuronium and tubocurarine in man. Anesthesia 27:415–422.CrossRefGoogle Scholar
  13. Dashief, R.M. (1985) d-Tubocurarine causes neuronal death when injected directly into the rat brain. Exp. Neurol. 89:172–188.CrossRefGoogle Scholar
  14. Docherty, J.R., and McGrath, J.C., (1980) A comparison of the effects of pancuronium bromide and its monoquaternary analogue, Org NC 45, on autonomic and somatic neurotransmission in the rat. Br. J. Pharmacology, 71, 225.CrossRefGoogle Scholar
  15. Docherty, J.R., and McGrath, J.C., (1978) Sympathomimetic effects of pancuronium bromide on the cardiovascular system of the pithed rat: a comparison with the effects of drugs blocking the neuronal uptake of noradrenaline. Br.J. Pharmacology, 64, 589.CrossRefGoogle Scholar
  16. Feldberg, W., Malcolm, J.L. and Sherwood, S.L (1956) Some effects of tubocurarine on electrical activity of cats brain. J.Physiol. (Lond.) 132:130–137.Google Scholar
  17. Foldes, F.F. (1960) The pharmacology of neuromuscular blocking agents in man. Clin.Pharmacol. Ther. 3:345–395.Google Scholar
  18. Foldes, F.F., Kobayashi, O., Kinjo, M., Hársing, LG.Jr, Nagashima, H., Duncalf, D., Goldiner, P.L. and Vizi, E.S. (1989) Presynaptic effect of muscle relaxants on the release of 3H-norepinephrine controlled by endogenous acetylcholine in guinea pig atrium. J.Neural Transm. 76:169–180.PubMedCrossRefGoogle Scholar
  19. Galindo, A.. (1971) Prejunctional effect of curare: its relative importance. J.Neurophysiol. 34:289–301.PubMedGoogle Scholar
  20. Grady, S., Marks, M.J., Wonnacott, S. and Collins, A.C. (1992) Characterization of nicotinic receptor-mediated [Hjdopamine release from synaptosomes prepared from mouse striatum. J.Neurochem. 59:848–856.PubMedCrossRefGoogle Scholar
  21. Hubbard, J.I. and Wilson, D.F. and Miyamoto, M. (1969) Reduction of transmitter release by d-tubocurarine. Nature 223:531–532.PubMedCrossRefGoogle Scholar
  22. Hunter, J.M. (1987) Adverse effects of neuromuscular blocking drugs. Br.J.Anaesth. 59:46–60.PubMedCrossRefGoogle Scholar
  23. Ivankovich, A.D., Miletich, D.J., Albrecht, R.F., and Zahed, G. (1975) The effect of pancuronium on myocardial contraction and catecholamine metabolism. J. Pharm. Pharmacol., 27, 837.PubMedCrossRefGoogle Scholar
  24. Kharkevits, D.A. (1986) Adamantyl compounds. In: Kharkevits, D.A. (Eds) New Neuromuscular Blocking Agents, pp. 473–478. Springer-Verlag. Berlin, Heidelberg, New York, Tokyo.CrossRefGoogle Scholar
  25. Kharkevich, D.A. and Shorr, V.A. (1986) Antimuscarinic and ganglion-blocking activity of neuromuscular blocking agents, In New Neuromuscular blocking agents (D.A Kharkevich, ed.) Springer Verlag, Berlin, 193–224.CrossRefGoogle Scholar
  26. Kinjo, M., Nagashima, N. and Vizi, E.S. (1989) Effect of atracurium and laudanosine on the release of 3H-noradrenaline. Br. J. Anaesth. 62:683–690.PubMedCrossRefGoogle Scholar
  27. Kobayashi, O., Nagashima, H., Duncalf, D., Chaudhry, I.A., Harsing, L.G. Jr. Foldes, F.F., Goldiner, P.L. and Vizi, E.S. (1987) Direct evidence that pancuronium and gallamine enhance the release of norepinephrine from the atrial sympathetic nerve by inhibiting prejunctional muscarinic receptors. J. of Autonomic Nerv. System 18:55–60.CrossRefGoogle Scholar
  28. Langley, J.N. (1905) On the reactions of cells and of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. J.Physiol.(Lond.) 33:374–413.Google Scholar
  29. Lee Son, S. and Waud, B.E. (1977) Potencies of neuromuscular blocking agents at the receptors of the atrial pacemaker and motor endplate of the guinea-pig. Anesthesiology 47:34–36.CrossRefGoogle Scholar
  30. Lee Son, S. and Waud, B.E. (1978) A vagolytic action of neuromuscular blocking agents at the pacemaker of the isolated guinea-pig atrium. Anesthesiology 48:191–194.CrossRefGoogle Scholar
  31. Lee Son, S. and Waud, D.R. (1980) Effects of non-depolarizing blocking agents on the cardiac vagus nerve in the guinea-pig. Br. J.Anaesthesia 52:981–986.CrossRefGoogle Scholar
  32. Lien, C.A. (1994) Rational use of muscle relaxants. Anesth. and Analg. (Suppl) pp.66–72.Google Scholar
  33. Manabe, N., Kinjo, M., Chaudhry, I.A., Goldiner, P.L, and Foldes, F.F. (1988) The effect of pancuronium on the release of acetylcholine from the right atrium of the guinea-pig. Anesthesiology 69:A517.CrossRefGoogle Scholar
  34. Marshall, R.J. (1980) Actions of non-depolarizing neuromuscular blocking agents at cholinoceptors other than at the motor endplate. In: Curares and Curahsation. (C.Conseiller, ed.) Labraire Arnette, Paris 257–274. interactionGoogle Scholar
  35. Marshall, R.J. and Ojewole, J.A.O. (1979) Comparison of the autonomic effects of some currently used neuromuscular blocking agents. Br.J.Pharmacol. 66:77–78.CrossRefGoogle Scholar
  36. Matkó, I., Fehér, E. and Vizi, E.S. (1994) Receptor mediated presynaptic modulation of the release of noradrenaline in human papillary muscle. Cardiovasc. Res. 28:700–704.PubMedCrossRefGoogle Scholar
  37. McGrath, J.C., Miller, R.D., Docherty, J.R., and Hamar, J.-C, (1980) Comparison of the cardiovascular actions of Org NC45 with those produced by other nondepolarizing neuromuscular blocking agents in experimental animals. Br. J. Anesth., 52:21 S.CrossRefGoogle Scholar
  38. Muscholl, E. (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am. J. Physiol. 239: H713–720.Google Scholar
  39. Nagashima, H., Vizi, E.S., Kobayashi, O., Kinjo, M., Duncalf, D., Goldiner, P.L, Foldes, F.F. (1986) Atracurium and laudanosine increase H-norepinephrine release from guinea pig atrium. Anesthesiology 65:A413.CrossRefGoogle Scholar
  40. Paton, W.D.M. (1957) Histamine release by compounds of simple chemical structure. Pharmacol. Rev. 9:169–187.Google Scholar
  41. Paton, W.D.M. (1959) The effects of muscle relaxants other than muscular relaxation. J.Anesth. 20:453–463.CrossRefGoogle Scholar
  42. Rapier, C, Lunt, G.G. and Wonnacott, S. (1990) Nicotinic modulation of [3H]dopamine release from striatal synaptosomes: pharmacological characterization. J.Neurochem. 54:937–945.PubMedCrossRefGoogle Scholar
  43. Riker, W.F. and Wescoe, W.C. (1951) Pharmacology of Flaxedil with observations on certain analogues. Ann.N.Y. Acad. Sci. 54:373–377.PubMedCrossRefGoogle Scholar
  44. Salt, P.J., Barnes, P.K. and Conway, CM. (1980) Inhibition of neuronal uptake of noradrenaline in the isolated perfused rat heart by pancuronium and its analogues, Org 6368, Org 7268 and NC 45. Br.J. Anaesthesia 52:313–317.CrossRefGoogle Scholar
  45. Sargent, P.B. (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16:403–443.PubMedCrossRefGoogle Scholar
  46. Seguela, P. Wadiche, J. Dineley-Miller K., Dani J.A. and Patrick, J.W. (1993) Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J Neurosci. 13:596–604.Google Scholar
  47. Smith, S.M. Brown, H.O., Toman, J.E.P. and Goodman, L (1947) Lack of cerebral effects of d-tubocurarine. Anesthesiology 8:1–9. Somogyi, G.T. Vizi, E.S., Chaudhry, L.A., Nagashima H., Duncalf.D., Foldes F.F. and Goldiner, P.L. (1987) Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation. Naunyn Schmiedeberg’s Arch. Pharmacol. 336:11–15.Google Scholar
  48. Somogyi, G.T. and Vizi, E.S. (1987) Positive and negative feedback modulation of CaO-dependent release of acetylcholine from mouse hemidiaphragm preparation. J. Physiol., 390:176.Google Scholar
  49. Stoelting, R.K. (1973) Hemodynamic effects of gallamine during halothane-nitrons oxide anaesthesia. Anesthesiology 39:645–647.PubMedCrossRefGoogle Scholar
  50. Storella, R.J., Timothy, S., Ackerman, B.S., Ziad, J. and Katul, B.S. (1993) Tetanic fade and acetylcholine release. Anesthesiology 79: A923.CrossRefGoogle Scholar
  51. Szenohradszky, J., Trevor, A.J., Bickler, P., Caldwell, J.E., Sharma, M.L., Rampil, I.J. and Miller, R.D. (1993) Central nervous system effects of intrathecal muscle relaxants in rats. Anesth. Analg. 76:1304–1309.PubMedGoogle Scholar
  52. Todorov, L., Windisch, K., Sershen, H., Papasova, M. and Vizi, E.S. (1991) Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens. Br. J.Pharmacol. 102:186–190.PubMedCrossRefGoogle Scholar
  53. Torocsik, A., Oberfrank, F., Sershen, H., Lajtha, A., Nemessy, K. and Vizi, E.S. (1991) Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202:297–302.PubMedCrossRefGoogle Scholar
  54. Torocsik, A., Oberfrank, F., Sershen, H., Lajtha, A., Nemessy, K. and Vizi, E.S. (1991) Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202:297–302.PubMedCrossRefGoogle Scholar
  55. Vemallis, A.B., Conroy, W.G. and Berg, D.X. (1993) Neurons assemble acetylcholine receptors with as many as three kinds of subunits while maintaining subunit regregation among receptor subtypes. Neuron, 10:451–464.CrossRefGoogle Scholar
  56. Vizi, E.S. (1973) Acetylcholine release from guinea-pig ileum by parasympathetic ganglion stimultants and gastrin-like polypeptides. Br. J. Pharmacol. 47:765–777.PubMedCrossRefGoogle Scholar
  57. Vizi, E.S. (1984) Non-synaptic Interactions Between Neurons: Modulation of Neurochemical Transmission. John Wiley and Sons, Chichester.Google Scholar
  58. Vizi, E.S. and Labos, E. (1989) Nonsynaptic interactions at pressynaptic level. Progr. in Neurobiol. 37:145–163.Google Scholar
  59. Vizi, E.S., Gyires, K., Somogyi, G.T. and Ungvah, G. (1983) Evidence that transmitter can be released from regions of the nerve cell other than presynaptic axon terminal axonal release of acetylcholine without modulation. Neuroscience 10:967–972.PubMedCrossRefGoogle Scholar
  60. Vizi, E.S., Kobayashi, O., Torocsik, A., Kinjo, M., Manabe, N., Goldioner, P.L., Potter, P.E. and Földes, F.F. (1989) Heterogeneity of presynaptic muscarinic receptors involved in modulation of transmitter release. Neuroscience 31:259–267.PubMedCrossRefGoogle Scholar
  61. Vizi, E.S., Kobayashi, O., Manabe, N., Nagashima, H., Foldes, F.F. (1990) Mechanism of the gallamine and pancuronium induced elevation of heart rate in guinea pigs. Anesth. Analg. 70:S450.CrossRefGoogle Scholar
  62. Vizi, E.S., Somogyi, G.T., Nagashima, H., Duncalf, D., Chaudhry, I.A., Kobayashi, O. and Foldes, F.F. (1987) d-Tubocurahne and Pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphraghm preparations. Br.J. Anaesth. 59:226–231.PubMedCrossRefGoogle Scholar
  63. Vizi, E.S., Somogyi, G.T., Nagashima, H., Duncalf, D., Chaudhry, I.A., and Foldes, F.F. (1985) d-Tubocurarine and pancuronium inhibitevoked release of acetycholine. Anesthesiology 63:A328.CrossRefGoogle Scholar
  64. Vizi, E.S., Sershen, H., Baila, A., Mike, A., Windisch, K., Juranyi, Zs., and Lajtha, A. (1994) Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nAChRs. Ann. N.Y. Acad. Sci. (in press).Google Scholar
  65. Ward, S., Boheimer, N., Weatherley, B.C., Simmonds, R.J. and Depson, T.A. (1987) Pharmacokinetics of atracuhum and its metabolites in patients with normal renal function, and in patients in renal failure. Brit. J. Anaesthesia 59:697–706.CrossRefGoogle Scholar
  66. Whiting, P. and Lindstrom, J. (1987) Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. USA 84:595–599.PubMedCrossRefGoogle Scholar
  67. Wessler, I., Karl, M., Mai, M. and Diener, A. (1987) Muscarine receptors on the rat phrenic nerve, evidence for positive and negative feedback mechanisms. Naunyn-Schmiedebergs Arch. Pharmacol. 335:605–612.PubMedCrossRefGoogle Scholar
  68. Wessler, I. and Kilbinger, H. (1986) Release of [3H]-acetylcholine from a modified rat phrenic nerve hemidiaphragm preparation, Naunyn-Schmiedebergs Arch. Pharmacol. 334:357–364.PubMedCrossRefGoogle Scholar
  69. Yu, Z.J. and Wecker, L. (1994) Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J.Neurochem., 63:186–194.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 1995

Authors and Affiliations

  • E. Sylvester Vizi
    • 1
    • 2
  1. 1.Institute of Experimental MedicineHungarian Academy of SciencesBudapestHungary
  2. 2.Department of PharmacologyI. Haynal Postgraduate Medical SchoolBudapestHungary

Personalised recommendations